TIFFANY HARKLEROAD: Open Payments
NPI 1174172142 · WAYCROSS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,248 in 139 payments from 42 companies in 2025. Trend: 2023 $4,790 · 2024 $3,737 · 2025 $4,248
Food & beverage: $3,819Education: $428
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $541 |
| SOBI, INC | 11 | $370 |
| Merck Sharp & Dohme LLC | 12 | $283 |
| E.R. Squibb & Sons, L.L.C. | 11 | $228 |
| Celgene Corporation | 6 | $228 |
| Tempus AI, Inc | 6 | $219 |
| AstraZeneca Pharmaceuticals LP | 9 | $190 |
| PFIZER INC. | 5 | $179 |
| ADC THERAPEUTICS AMERICA, INC. | 3 | $179 |
| Novocure Inc. | 3 | $170 |
Products named: RYBREVANT, KEYTRUDA, REBLOZYL, XT CDX, Vonjo, ZYNLONTA, OPDIVO, Optune Lua (NovoTTF-200T).
Industry payments across GA — which companies pay providers there.
